How much does Provocholine (Methacholine Chloride Powder for Solution for Inhalation) Cost& price without insurance in China?

Provocholine® is the commercial brand name of methacholine chloride, a direct‑acting cholinergic agonist developed by Methapharm Inc. It stimulates muscarinic receptors on bronchial smooth muscle to induce reversible bronchoconstriction, which is applied for bronchial provocation testing. Tianqing Suxin® is its domestic generic product available in China.

Main Indications
Bronchial provocation test to assist the diagnosis of bronchial asthma in patients with suspected asthma whose baseline FEV1 is ≥70% of the predicted value.

Clinical Research
Clinical studies demonstrated that methacholine challenge test has high sensitivity for detecting airway hyperresponsiveness. A positive test result is defined as a ≥20% reduction in FEV1 after inhalation of cumulative graded doses. This test helps differentiate asthma from other disorders presenting with non-specific respiratory symptoms, and resuscitation equipment and rescue medication must be readily available during testing. The domestic generic development referenced the clinical data of Provocholine®.

Common Side Effects
Systemic reactions: hypotension, palpitations;
Common mild adverse reactions: cough, headache, throat irritation, dyspnea. Rare but severe: severe bronchospasm, serious hypersensitivity reactions.

Approval Status in China
Original drug Provocholine® has not been approved for marketing in mainland China. The domestic generic drug TianqingSuxin® (Methacholine Chloride Powder for Solution for Inhalation) was officially approved for marketing in China in 2023, with the specification of 100mg per vial, 1 vial per box. It is currently a prescription diagnostic drug.

Buy Provocholine (Methacholine Chloride Powder for Solution for Inhalation) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.

Share your love

Newsletter Updates

Enter your email address below and subscribe to our newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *